The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Speciality Drugs Market Research Report 2025
Synopsis
The global Pet Speciality Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 48%.
This report aims to provide a comprehensive presentation of the global market for Pet Speciality Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Speciality Drugs.
Report Scope
The Pet Speciality Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Speciality Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Speciality Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Bayer
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Vetoquinol
Virbac
Wedgewood Pharmacy
Lee Silsby Compounding Pharmacy
Golden Gate Veterinary Compounding Pharmacy
CAHIC
Ringpu
Segment by Type
Antibiotics
Anti-inflammatory Drugs
Vaccines
Parasiticides
Skin Care Products
Others
Segment by Application
Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Speciality Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pet Speciality Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 48%.
This report aims to provide a comprehensive presentation of the global market for Pet Speciality Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Speciality Drugs.
Report Scope
The Pet Speciality Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Speciality Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Speciality Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Bayer
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Vetoquinol
Virbac
Wedgewood Pharmacy
Lee Silsby Compounding Pharmacy
Golden Gate Veterinary Compounding Pharmacy
CAHIC
Ringpu
Segment by Type
Antibiotics
Anti-inflammatory Drugs
Vaccines
Parasiticides
Skin Care Products
Others
Segment by Application
Dogs
Cats
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Speciality Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Speciality Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antibiotics
1.2.3 Anti-inflammatory Drugs
1.2.4 Vaccines
1.2.5 Parasiticides
1.2.6 Skin Care Products
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pet Speciality Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dogs
1.3.3 Cats
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Speciality Drugs Market Perspective (2019-2030)
2.2 Pet Speciality Drugs Growth Trends by Region
2.2.1 Global Pet Speciality Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pet Speciality Drugs Historic Market Size by Region (2019-2024)
2.2.3 Pet Speciality Drugs Forecasted Market Size by Region (2025-2030)
2.3 Pet Speciality Drugs Market Dynamics
2.3.1 Pet Speciality Drugs Industry Trends
2.3.2 Pet Speciality Drugs Market Drivers
2.3.3 Pet Speciality Drugs Market Challenges
2.3.4 Pet Speciality Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Speciality Drugs Players by Revenue
3.1.1 Global Top Pet Speciality Drugs Players by Revenue (2019-2024)
3.1.2 Global Pet Speciality Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Pet Speciality Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Speciality Drugs Revenue
3.4 Global Pet Speciality Drugs Market Concentration Ratio
3.4.1 Global Pet Speciality Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Speciality Drugs Revenue in 2023
3.5 Pet Speciality Drugs Key Players Head office and Area Served
3.6 Key Players Pet Speciality Drugs Product Solution and Service
3.7 Date of Enter into Pet Speciality Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Speciality Drugs Breakdown Data by Type
4.1 Global Pet Speciality Drugs Historic Market Size by Type (2019-2024)
4.2 Global Pet Speciality Drugs Forecasted Market Size by Type (2025-2030)
5 Pet Speciality Drugs Breakdown Data by Application
5.1 Global Pet Speciality Drugs Historic Market Size by Application (2019-2024)
5.2 Global Pet Speciality Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pet Speciality Drugs Market Size (2019-2030)
6.2 North America Pet Speciality Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pet Speciality Drugs Market Size by Country (2019-2024)
6.4 North America Pet Speciality Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Speciality Drugs Market Size (2019-2030)
7.2 Europe Pet Speciality Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pet Speciality Drugs Market Size by Country (2019-2024)
7.4 Europe Pet Speciality Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Speciality Drugs Market Size (2019-2030)
8.2 Asia-Pacific Pet Speciality Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pet Speciality Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Pet Speciality Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Speciality Drugs Market Size (2019-2030)
9.2 Latin America Pet Speciality Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pet Speciality Drugs Market Size by Country (2019-2024)
9.4 Latin America Pet Speciality Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Speciality Drugs Market Size (2019-2030)
10.2 Middle East & Africa Pet Speciality Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pet Speciality Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Pet Speciality Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Detail
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Pet Speciality Drugs Introduction
11.1.4 Zoetis Revenue in Pet Speciality Drugs Business (2019-2024)
11.1.5 Zoetis Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Pet Speciality Drugs Introduction
11.2.4 Merck Revenue in Pet Speciality Drugs Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Pet Speciality Drugs Introduction
11.3.4 Bayer Revenue in Pet Speciality Drugs Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Elanco
11.4.1 Elanco Company Detail
11.4.2 Elanco Business Overview
11.4.3 Elanco Pet Speciality Drugs Introduction
11.4.4 Elanco Revenue in Pet Speciality Drugs Business (2019-2024)
11.4.5 Elanco Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Pet Speciality Drugs Introduction
11.5.4 Boehringer Ingelheim Revenue in Pet Speciality Drugs Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Ceva Sante Animale
11.6.1 Ceva Sante Animale Company Detail
11.6.2 Ceva Sante Animale Business Overview
11.6.3 Ceva Sante Animale Pet Speciality Drugs Introduction
11.6.4 Ceva Sante Animale Revenue in Pet Speciality Drugs Business (2019-2024)
11.6.5 Ceva Sante Animale Recent Development
11.7 Vetoquinol
11.7.1 Vetoquinol Company Detail
11.7.2 Vetoquinol Business Overview
11.7.3 Vetoquinol Pet Speciality Drugs Introduction
11.7.4 Vetoquinol Revenue in Pet Speciality Drugs Business (2019-2024)
11.7.5 Vetoquinol Recent Development
11.8 Virbac
11.8.1 Virbac Company Detail
11.8.2 Virbac Business Overview
11.8.3 Virbac Pet Speciality Drugs Introduction
11.8.4 Virbac Revenue in Pet Speciality Drugs Business (2019-2024)
11.8.5 Virbac Recent Development
11.9 Wedgewood Pharmacy
11.9.1 Wedgewood Pharmacy Company Detail
11.9.2 Wedgewood Pharmacy Business Overview
11.9.3 Wedgewood Pharmacy Pet Speciality Drugs Introduction
11.9.4 Wedgewood Pharmacy Revenue in Pet Speciality Drugs Business (2019-2024)
11.9.5 Wedgewood Pharmacy Recent Development
11.10 Lee Silsby Compounding Pharmacy
11.10.1 Lee Silsby Compounding Pharmacy Company Detail
11.10.2 Lee Silsby Compounding Pharmacy Business Overview
11.10.3 Lee Silsby Compounding Pharmacy Pet Speciality Drugs Introduction
11.10.4 Lee Silsby Compounding Pharmacy Revenue in Pet Speciality Drugs Business (2019-2024)
11.10.5 Lee Silsby Compounding Pharmacy Recent Development
11.11 Golden Gate Veterinary Compounding Pharmacy
11.11.1 Golden Gate Veterinary Compounding Pharmacy Company Detail
11.11.2 Golden Gate Veterinary Compounding Pharmacy Business Overview
11.11.3 Golden Gate Veterinary Compounding Pharmacy Pet Speciality Drugs Introduction
11.11.4 Golden Gate Veterinary Compounding Pharmacy Revenue in Pet Speciality Drugs Business (2019-2024)
11.11.5 Golden Gate Veterinary Compounding Pharmacy Recent Development
11.12 CAHIC
11.12.1 CAHIC Company Detail
11.12.2 CAHIC Business Overview
11.12.3 CAHIC Pet Speciality Drugs Introduction
11.12.4 CAHIC Revenue in Pet Speciality Drugs Business (2019-2024)
11.12.5 CAHIC Recent Development
11.13 Ringpu
11.13.1 Ringpu Company Detail
11.13.2 Ringpu Business Overview
11.13.3 Ringpu Pet Speciality Drugs Introduction
11.13.4 Ringpu Revenue in Pet Speciality Drugs Business (2019-2024)
11.13.5 Ringpu Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pet Speciality Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Antibiotics
Table 3. Key Players of Anti-inflammatory Drugs
Table 4. Key Players of Vaccines
Table 5. Key Players of Parasiticides
Table 6. Key Players of Skin Care Products
Table 7. Key Players of Others
Table 8. Global Pet Speciality Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Pet Speciality Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Pet Speciality Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Pet Speciality Drugs Market Share by Region (2019-2024)
Table 12. Global Pet Speciality Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Pet Speciality Drugs Market Share by Region (2025-2030)
Table 14. Pet Speciality Drugs Market Trends
Table 15. Pet Speciality Drugs Market Drivers
Table 16. Pet Speciality Drugs Market Challenges
Table 17. Pet Speciality Drugs Market Restraints
Table 18. Global Pet Speciality Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Pet Speciality Drugs Market Share by Players (2019-2024)
Table 20. Global Top Pet Speciality Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Speciality Drugs as of 2023)
Table 21. Ranking of Global Top Pet Speciality Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Pet Speciality Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Pet Speciality Drugs Product Solution and Service
Table 25. Date of Enter into Pet Speciality Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pet Speciality Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Pet Speciality Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Pet Speciality Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Pet Speciality Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Pet Speciality Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Pet Speciality Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Pet Speciality Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Pet Speciality Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Pet Speciality Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Pet Speciality Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Pet Speciality Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Pet Speciality Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Pet Speciality Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Pet Speciality Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Pet Speciality Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Pet Speciality Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Pet Speciality Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Pet Speciality Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Pet Speciality Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Pet Speciality Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Pet Speciality Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Pet Speciality Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Pet Speciality Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Zoetis Company Detail
Table 51. Zoetis Business Overview
Table 52. Zoetis Pet Speciality Drugs Product
Table 53. Zoetis Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 54. Zoetis Recent Development
Table 55. Merck Company Detail
Table 56. Merck Business Overview
Table 57. Merck Pet Speciality Drugs Product
Table 58. Merck Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 59. Merck Recent Development
Table 60. Bayer Company Detail
Table 61. Bayer Business Overview
Table 62. Bayer Pet Speciality Drugs Product
Table 63. Bayer Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 64. Bayer Recent Development
Table 65. Elanco Company Detail
Table 66. Elanco Business Overview
Table 67. Elanco Pet Speciality Drugs Product
Table 68. Elanco Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 69. Elanco Recent Development
Table 70. Boehringer Ingelheim Company Detail
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Pet Speciality Drugs Product
Table 73. Boehringer Ingelheim Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Ceva Sante Animale Company Detail
Table 76. Ceva Sante Animale Business Overview
Table 77. Ceva Sante Animale Pet Speciality Drugs Product
Table 78. Ceva Sante Animale Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 79. Ceva Sante Animale Recent Development
Table 80. Vetoquinol Company Detail
Table 81. Vetoquinol Business Overview
Table 82. Vetoquinol Pet Speciality Drugs Product
Table 83. Vetoquinol Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 84. Vetoquinol Recent Development
Table 85. Virbac Company Detail
Table 86. Virbac Business Overview
Table 87. Virbac Pet Speciality Drugs Product
Table 88. Virbac Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 89. Virbac Recent Development
Table 90. Wedgewood Pharmacy Company Detail
Table 91. Wedgewood Pharmacy Business Overview
Table 92. Wedgewood Pharmacy Pet Speciality Drugs Product
Table 93. Wedgewood Pharmacy Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 94. Wedgewood Pharmacy Recent Development
Table 95. Lee Silsby Compounding Pharmacy Company Detail
Table 96. Lee Silsby Compounding Pharmacy Business Overview
Table 97. Lee Silsby Compounding Pharmacy Pet Speciality Drugs Product
Table 98. Lee Silsby Compounding Pharmacy Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 99. Lee Silsby Compounding Pharmacy Recent Development
Table 100. Golden Gate Veterinary Compounding Pharmacy Company Detail
Table 101. Golden Gate Veterinary Compounding Pharmacy Business Overview
Table 102. Golden Gate Veterinary Compounding Pharmacy Pet Speciality Drugs Product
Table 103. Golden Gate Veterinary Compounding Pharmacy Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 104. Golden Gate Veterinary Compounding Pharmacy Recent Development
Table 105. CAHIC Company Detail
Table 106. CAHIC Business Overview
Table 107. CAHIC Pet Speciality Drugs Product
Table 108. CAHIC Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 109. CAHIC Recent Development
Table 110. Ringpu Company Detail
Table 111. Ringpu Business Overview
Table 112. Ringpu Pet Speciality Drugs Product
Table 113. Ringpu Revenue in Pet Speciality Drugs Business (2019-2024) & (US$ Million)
Table 114. Ringpu Recent Development
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Speciality Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pet Speciality Drugs Market Share by Type: 2023 VS 2030
Figure 3. Antibiotics Features
Figure 4. Anti-inflammatory Drugs Features
Figure 5. Vaccines Features
Figure 6. Parasiticides Features
Figure 7. Skin Care Products Features
Figure 8. Others Features
Figure 9. Global Pet Speciality Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Pet Speciality Drugs Market Share by Application: 2023 VS 2030
Figure 11. Dogs Case Studies
Figure 12. Cats Case Studies
Figure 13. Other Case Studies
Figure 14. Pet Speciality Drugs Report Years Considered
Figure 15. Global Pet Speciality Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Pet Speciality Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Pet Speciality Drugs Market Share by Region: 2023 VS 2030
Figure 18. Global Pet Speciality Drugs Market Share by Players in 2023
Figure 19. Global Top Pet Speciality Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Speciality Drugs as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Pet Speciality Drugs Revenue in 2023
Figure 21. North America Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Pet Speciality Drugs Market Share by Country (2019-2030)
Figure 23. United States Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Pet Speciality Drugs Market Share by Country (2019-2030)
Figure 27. Germany Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Pet Speciality Drugs Market Share by Region (2019-2030)
Figure 35. China Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Pet Speciality Drugs Market Share by Country (2019-2030)
Figure 43. Mexico Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Pet Speciality Drugs Market Share by Country (2019-2030)
Figure 47. Turkey Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Pet Speciality Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Zoetis Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 50. Merck Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 51. Bayer Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 52. Elanco Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 54. Ceva Sante Animale Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 55. Vetoquinol Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 56. Virbac Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 57. Wedgewood Pharmacy Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 58. Lee Silsby Compounding Pharmacy Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 59. Golden Gate Veterinary Compounding Pharmacy Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 60. CAHIC Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 61. Ringpu Revenue Growth Rate in Pet Speciality Drugs Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
